Streamlined Research Ethics Review Launched by Clinical Trials Ontario
System provides nimble, efficient review of multi-centre clinical trials, while maintaining highest ethical standards
A new streamlined approach for the ethical review and oversight of multi-center clinical trials in Ontario was launched by Clinical Trials Ontario (CTO), a stakeholder-led organization established by the Government of Ontario in 2012.
The CTO Streamlined Research Ethics Review System allows any single ‘CTO Qualified’ research ethics board in Ontario to provide ethical review and oversight on behalf of multiple research sites involved in a clinical trial. This replaces the current approach to conduct a research ethics review at each institution participating in the same clinical trial.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
